Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the epigenetic drug discovery landscape
Veda Prachayasittikul, Philip Prathipati, Reny Pratiwi, et al.
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 4, pp. 345-362
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Recent developments of HDAC inhibitors: Emerging indications and novel molecules
Andrey D. Bondarev, Misty M. Attwood, Jörgen Jönsson, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 12, pp. 4577-4597
Open Access | Times Cited: 286
Epidrugs: targeting epigenetic marks in cancer treatment
Cristiana Libardi Miranda Furtado, Maria Cláudia dos Santos Luciano, Renan da Silva Santos, et al.
Epigenetics (2019) Vol. 14, Iss. 12, pp. 1164-1176
Open Access | Times Cited: 284
Histone Modifications Form Epigenetic Regulatory Networks to Regulate Abiotic Stress Response
Minoru Ueda, Motoaki Seki
PLANT PHYSIOLOGY (2019) Vol. 182, Iss. 1, pp. 15-26
Open Access | Times Cited: 175
Emerging role of PI3K/AKT in tumor-related epigenetic regulation
Qi Yang, Wei Jiang, Peng Hou
Seminars in Cancer Biology (2019) Vol. 59, pp. 112-124
Closed Access | Times Cited: 162
An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review
Zahra Sahafnejad, Shahin Ramazi, Abdollah Allahverdi
Genes (2023) Vol. 14, Iss. 4, pp. 873-873
Open Access | Times Cited: 44
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 132
The state of the art in secondary pharmacology and its impact on the safety of new medicines
Richard Brennan, Stephen Jenkinson, Andrew J. Brown, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 525-545
Closed Access | Times Cited: 13
Role of Epigenomics in Bone and Cartilage Disease
Joyce B. J. van Meurs, Cindy G. Boer, Laura López-Delgado, et al.
Journal of Bone and Mineral Research (2019) Vol. 34, Iss. 2, pp. 215-230
Open Access | Times Cited: 74
Human endogenous retroviruses role in cancer cell stemness
Claudia Matteucci, Emanuela Balestrieri, Ayele Argaw-Denboba, et al.
Seminars in Cancer Biology (2018) Vol. 53, pp. 17-30
Closed Access | Times Cited: 68
Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
Michel Montalvo-Casimiro, Rodrigo González‐Barrios, Marco Antonio Meraz-Rodriguez, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 65
Current paradigms in epigenetic anticancer therapeutics and future challenges
Manoj Singh, Vikas Kumar, Nirmala Sehrawat, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 422-440
Closed Access | Times Cited: 52
Therapies Targeting Epigenetic Alterations in Acute Kidney Injury-to-Chronic Kidney Disease Transition
Fumiaki Tanemoto, Imari Mimura
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 123-123
Open Access | Times Cited: 33
Novel epigenetic therapeutic strategies and targets in cancer
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166552-166552
Open Access | Times Cited: 32
Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
Sk. Abdul Amin, Samima Khatun, Shovanlal Gayen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115594-115594
Closed Access | Times Cited: 19
Epigenetic regulation in premature ovarian failure: A literature review
Jing Wang, Xiguang Sun, Zongxing Yang, et al.
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 17
Epigenetic Regulation in Melanoma: Facts and Hopes
Emilio Francesco Giunta, Gianluca Arrichiello, Marcello Curvietto, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2048-2048
Open Access | Times Cited: 34
Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates
Abdelhakim Bouyahya, Naoufal El Hachlafi, Tarik Aanniz, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2568-2568
Open Access | Times Cited: 24
Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat
Nasreddine El Omari, Asaad Khalid, Hafiz A. Makeen, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33052-e33052
Open Access | Times Cited: 5
Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP
Beth E. Zucconi, Jessica L. Makofske, David J. Meyers, et al.
Biochemistry (2019) Vol. 58, Iss. 16, pp. 2133-2143
Open Access | Times Cited: 42
Multifaceted Functions and Novel Insight Into the Regulatory Role of RNA N6-Methyladenosine Modification in Musculoskeletal Disorders
Wenchao Zhang, Lile He, Zhongyue Liu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 34
Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
Wenjing Xiao, Qiaodan Zhou, Xudong Wen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 29
Molecular mechanisms underlying the clinical efficacy of panobinostat involve Stochasticity of epigenetic signaling, sensitization to anticancer drugs, and induction of cellular cell death related to cellular stresses
Nasreddine El Omari, Saad Bakrim, Asaad Khalid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114886-114886
Open Access | Times Cited: 13
Promise of G-Quadruplex Structure Binding Ligands as Epigenetic Modifiers with Anti-Cancer Effects
Antara Sengupta, Akansha Ganguly, Shantanu Chowdhury
Molecules (2019) Vol. 24, Iss. 3, pp. 582-582
Open Access | Times Cited: 33
Peptides as epigenetic modulators: therapeutic implications
Yorick Janssens, Evelien Wynendaele, Wim Vanden Berghe, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways
John Kaszycki, Minji Kim
Frontiers in Immunology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top